Drug firm to seek talks with Nobel laureate Tasuku Honjo with new proposal

Ono Pharmaceutical Co., which sells a cancer treatment drug based on the discoveries of Japanese Nobel laureate in medicine Tasuku Honjo, has decided to make a new proposal to him in an attempt to settle a dispute over a license fee, a company source said Saturday.Ono Pharmaceutical, which started selling the drug Opdivo in 2014, will revise its earlier plan of donating up to 30 billion yen ($276 million) to Kyoto University where Honjo is a distinguished professor, the source said, adding, "It won't be good for both sides if the conflict is prolonged. We need to have discussions."Honjo sai…READ FULL ARTICLE